# Glaxo Wellcome Manufacturing Pte Limited – FDA Inspection, Jun 1, 2018

Source: https://www.keypedia.com/records/fda_inspections/glaxo-wellcome-manufacturing-pte-limited/bb19f612-9f12-414c-b441-03e54b595aa4
Source feed: FDA_Inspections

> FDA inspection 1055375 of Glaxo Wellcome Manufacturing Pte Limited, June 01, 2018. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1055375
- Company Name: Glaxo Wellcome Manufacturing Pte Limited
- Inspection Date: 2018-06-01
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1275331 - 2023-10-13
- FDA Inspection 1191253 - 2022-09-02
- FDA Inspection 865559 - 2014-01-16
- FDA Inspection 807638 - 2012-11-16
- FDA Inspection 572094 - 2009-03-13

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/jose-e-melendez/75bd6083-14a4-4bd2-a0e5-9946d4dd37e1)

Company: https://www.keypedia.com/companies/glaxo-wellcome-manufacturing-pte-limited/5bc5ffcf-9696-4708-86c1-f63fb5a0fc28

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c